The QualityStocks Daily Friday, January 18th, 2019

Today's Top 3 StockMarketWatch

QualityStocks (NDMT) +100.00%

PoliticsAndMyPortfolio (GCFB) +66.67%

StockMarketWatch (AVCO) +34.94%

The QualityStocks Daily Stock List

Sierra Monitor Corp. (SRMC)

MicroCap Gems, Wallet Investor, Marketbeat, Dividend Investor, SmallCapVoice, Morningstar, Penny Stock Hub, Business Insider, Stockopedia, Wallmine, Marketwired, Wall Street Resources, Simply Wall St, Stockwatch, 4-Traders, Capital Cube, Stock News Now, Zacks, and The Street reported previously on Sierra Monitor Corp. (SRMC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sierra Monitor Corp. is a provider of Industrial Internet of Things (IIoT) solutions that target facility automation and facility safety requirements. The Company’s FieldServer brand of protocol gateways is used by system integrators and original equipment manufacturers (OEMs) to enable local and remote monitoring and control of assets and facilities. FieldServer is the industry’s leading-protocol gateway, with greater than 200,000 products, supporting more than 140 protocols, installed in industrial and commercial facilities.

OTCQB-listed, Sierra Monitor is headquartered in Milpitas, California. Sierra Monitor earlier formally incorporated Sierra Monitor South Africa. The office in Johannesburg provides engineering and customer support services to Sierra Monitor around the world.

Sierra Monitor’s industry-leading BACnet gateways, routers, and network explorers are now "IIoT-Empowered out-of-the-box". They are shipping with new software that allows customers to securely register, access, and manage their field-installed products from Sierra Monitor’s FieldPoP™ device cloud.

The Company offers its BACnet Explorer NG. This is the industry’s first cloud-connected network discovery and management solution for BACnet networks. BACnet is an industry-standard protocol extensively used in building and facility automation.

The combination of the “plug-and-play” BACnet Explorer NG appliance and Sierra Monitor’s FieldPoP™ device cloud enables installers and system integrators to seamlessly and remotely discover and manage BACnet MS/TP and BACnet/IP devices on an automation network, test newly installed devices, debug the network, upload device and network information to the cloud, integrate device and network data with sophisticated cloud-based software applications, and provide a control path back to the network and devices.

The Company’s Sentry IT fire and gas detection solutions are used by industrial and commercial facilities managers to protect their personnel and assets. The latest Sentry IT controller easily consolidates up to 32 separate toxic and/or combustible gas sensors into a single interface panel.

Recently, Sierra Monitor announced the availability of a new line of flame detection products. The Company said that the new 39xx series flame detectors meet or surpass customer expectations as they go well beyond industry performance standards.

Mr. Jonathan Breede, Flame and Gas Detection Product Manager for Sierra Monitor, said, “I am beyond excited about our new flame detectors – we have been working on offering an improved flame detection solution for a long time, and the 39xx series does not disappoint. All three models have something unique and attractive about them making them well suited for diverse environments and applications.”

Sierra Monitor’s device management cloud service for equipment manufacturers was verified secure by Provensec. The SMC Cloud is used by Sierra Monitor and its customers to collect and analyze operational and telemetry data from connected facilities and industrial equipment. This includes HVAC, industrial lighting, boilers, fire-panels, flow/valve controls and many more. Provensec is an industry-recognized leader in cyber security testing and risk management services. Sierra Monitor turned to Provensec to confirm the security and accessibility of SMC Cloud.

Sierra Monitor Corp. (SRMC), closed Friday's trading session at $1.85, down 2.63%, on 800 volume with 1 trade. The average volume for the last 3 months is 3,330 and the stock's 52-week low/high is $1.20/$2.17.


CV Sciences, Inc. (CVSI)

Penny Picks, MarketWatch, Proactive Investors, PennyStockScholar, Wall Street Mover, Damn Good Penny Picks, OTCtipReporter, Wealth Insider Alert, StreetAuthority Daily, Profitable Trader Authority, Business Wire, Morningstar, Promotion Stock Secrets, Investor Place, Stock Commander, Barchart, and Streetwise Reports reported earlier on CV Sciences, Inc. (CVSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CV Sciences, Inc. concentrates on developing and commercializing novel therapeutics using synthetic Cannabidiol (CBD). The Company operates two divisions -Pharmaceuticals and Consumer Products. These divisions are supported by its medical and scientific advisory board, and state-of-the-art production facilities. The Company formerly went by the name CannaVEST Corp. It changed its corporate name to CV Sciences, Inc. in January of 2016. A life science enterprise, CV Sciences has main offices and facilities in Las Vegas, Nevada, and San Diego, California.

The Company’s Pharmaceutical Division is developing synthetically-formulated cannabidiol-based medicine. It is pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications using cannabidiol as the active pharmaceutical ingredient. CV Sciences has realized promising preclinical results in the development of cannabinoid medicines for the treatment of a variety of medical conditions.

CV Sciences’ Consumer Products Division delivers botanical-based cannabidiol products that enhance quality of life. Each consumer products brand is backed by a formal safety review, an increasing body of case reports, and physicians’ recommendations.

Fundamentally, CV Sciences is a leading supplier and manufacturer of hemp-derived phytocannabinoids, including CBD oil, and a developer of specialty pharmaceutical therapeutics. CV Sciences acquired CanX in December of 2015. CanX is a Pre-Clinical drug development company. It is focusing on significant unmet medical needs.

CanX’s initial drug candidate is CVSI-007. CVSI-007 chewing gum combines CBD and Nicotine. It is patent pending. CVSI-007 is a proprietary chewing gum. It combines synthetic CBD and nicotine to effectively treat smokeless tobacco addiction.

Moreover, CV Sciences manufactures, markets, and sells plant-based CBD products under the PlusCBD brand. This is for an array of market sectors. These include nutraceutical, beauty care, specialty foods, and vape.

Recently, CV Sciences announced its certification by the US Hemp Authority™ Guidance Program. Established in 2018, the US Hemp Authority™ Certified program was developed by the US Hemp Roundtable. The specific design of it is to educate hemp farmers and hemp finished product producers in FDA Current Good Manufacturing Practices (cGMP) and Good Agricultural Practices (GAP) to ensure that consistent quality is attained. CV Sciences is now licensed to use the Certified Seal of the US Hemp Authority™ in its product labeling, marketing, and advertising of PlusCBD Oil™ products.

CV Sciences, Inc. (CVSI), closed Friday's trading session at $4.38, up 4.91%, on 1,349,622 volume with 2,104 trades. The average volume for the last 3 months is 1,309,414 and the stock's 52-week low/high is $0.321/$9.19.


Escalon Medical Corp. (ESMC)

Stock Twits, Dividend Investor, Zacks, Morningstar, Market Screener, Simply Wall St, Wallet Investor, OTC Picks, MarketWatch, last10k, GuruFocus, Capital Cube, Stockhouse, last10k, Equity Clock, Wall Street Resources, FeedBlitz, PennyToBuck, 4-Traders, InvestorsHub, and YCharts reported previously on Escalon Medical Corp. (ESMC), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Escalon Medical Corp. specializes in the development, marketing, and distribution of ophthalmic diagnostic imaging and surgical products. It is working to grow its ophthalmic business through concentrating on its existing products, developing new products, utilizing strategic partnerships, and through acquisition.

Escalon Medical has its corporate headquarters in Wayne, Pennsylvania. The Company also has operations in Lake Success, New York; New Berlin, Wisconsin, and Stoneham, Massachusetts. Escalon Medical’s shares trade on the OTC Markets Group’s OTCQB.

Escalon Medical primarily markets to teaching institutions, hospitals, and eye surgery centers. The Company acquired Sonomed, Inc. in 2000. Since then, by way of acquisition, product divestitures, partnerships, and product development, it has grown and expanded its product offerings. Sonomed, Inc. and Escalon Medical Imaging are wholly-owned subsidiaries of Escalon Medical Corp.

Escalon Medical’s products include an assortment of ophthalmic ultrasound, digital imaging and photography, and image management systems. In addition, its products include surgical products, including intraocular gases, fiber optic light guides and sources, and other surgical vitreoretinal instruments.

All of the Company’s ophthalmic products are branded as Sonomed Escalon. Furthermore, Sonomed Escalon maintains certification for compliance with ISO1385 Quality Management Systems for Medical Devices.

Sonomed Escalon provides ultrasound, digital photography, and image management systems. Sonomed Escalon Rx products include mydriatics/cyclopegics; diagnostic supplies; anesthetics/combo products; antibiotics, steroid combination; injectable dyes, surgical products, and office products.

Concerning tonometry, Sonomed Escalon has its “diatom IOP measuring device.” This involves measuring IOP through the eyelid on sclera with no corneal contact. It rapidly provides accurate IOP reading independent of corneal thickness. Additionally, it is ideal for cases where standard tonometry cannot be used. No anesthesia is required and there is no need to remove contact lenses, no need for sterilization, and no patient discomfort or anxiety.

Moreover, surgical solutions offered include vitreoretinal gases and devices. Its diagnostic solutions include AXIS image management; ophthalmic ultrasound; mobile vision analysis; adaptive refractor; perimetry; digital imaging, and tonometry.

Sonomed Escalon offers its Vu Pad pertaining to Ophthalmic Ultrasound. This is a new class of ophthalmic ultrasound versatility. Vu Pad is configurable with B-scan, A-scan, UBM or any combination.

Escalon Medical established in 1987. The Company sells its products to medical institutions by way of independent sales representatives, a network of distributors, and internal sales employees.

Escalon Medical Corp. (ESMC), closed Friday's trading session at $0.1716, up 27.11%, on 72,110 volume with 11 trades. The average volume for the last 3 months is 11,590 and the stock's 52-week low/high is $0.1082/$0.36.


Freedom Leaf, Inc. (FRLF)

InvestorsHub, OTC Markets, Stockhouse, Penny Stock Tweets, CFN Media Group, SmallCapVoice, MicroSmallCap, Promotion Stock Secrets, Daily Marijuana Observer, and Stocks To Buy Now reported earlier on Freedom Leaf, Inc. (FRLF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a group of international, vertically integrated hemp businesses and cannabis media companies. It is a leading go-to resource in the cannabis, medical marijuana, as well as industrial hemp industry. The Company is building a diverse portfolio of valuable businesses via strategic mergers, acquisitions, and acceleration projects across the industry. Leafceuticals, Inc. is a wholly-owned division of Freedom Leaf. OTCQB-listed, Freedom Leaf has its corporate headquarters in Las Vegas, Nevada.

The Company targets acquisitions of high growth and niche companies. Freedom Leaf’s strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development. Freedom Leaf does not handle, grow, sell, or disperse marijuana.

Freedom Leaf’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-developing and changing cannabis, medical marijuana, and industrial hemp industry.

Hempology® is Freedom Leaf’s exclusively branded product line. Hempology® is now vertically integrated from seed to consumer, processing CBD and a whole spectrum of whole-hemp extracts for the entourage-effect. In addition, Freedom Leaf has its hemp-based rolling paper company, Plants to Paper.

Freedom Leaf has its This is the Spanish Speaking community's leading cannabis website. Furthermore, Freedom Leaf has its This is the largest Medical Cannabis information website in Spanish.

Freedom Leaf earlier acquired 100 percent of Green Market Europe S.L. (GME). GME is a Spanish producer of hemp products. Additionally, Freedom Leaf acquired 100 percent of Tierra Science Global, LLC. Tierra specializes in health supplements supporting peak bio-energy levels in humans. Moreover, Freedom Leaf has acquired the Irie CBD Product Line. This includes virtually all assets, trademarks, formulating equipment, formulas and products. Irie is a California-based CBD, "Cannabidiol", product line. Freedom Leaf is also entering the CBD beverage category with the acquisition of Hemp2o Beverage Company.

Recently, Pura Naturals, Inc. (PNAT) and Freedom Leaf jointly announced a Strategic Alliance Agreement between the companies. Pura Naturals makes eco-friendly, earth-conscious health and beauty products. Freedom Leaf will supply CBD to Pura Naturals as part of Pura's health and beauty line of products that contain CBD. The Pura Health and Beauty Line will feature "IrieCBD Inside" with Freedom Leaf receiving a royalty. Also, Freedom Leaf will assist with marketing, distribution and sales of Pura's products and receive a fee for this work.

Freedom Leaf, Inc. (FRLF), closed Friday's trading session at $0.265, up 2.32%, on 266,103 volume with 42 trades. The average volume for the last 3 months is 1,082,867 and the stock's 52-week low/high is $0.70835/$0.795.


Surna, Inc. (SRNA)

PricelessPennyStocks, MarketWatch, Stockhouse, InvestorsHub, Market Wire Stocks, Best Medical Marijuana Stocks, Value Penny Stocks, Cannabis Financial Network News, SmallCapVoice, Hot Stock Profits, Ascending Stocks, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, Marketbeat, CFN Media Group, PennyStockRumors, DSR News, Greenbackers, PHUB News, Actual Gains, and OTC Stock Review reported previously on Surna, Inc. (SRNA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Surna, Inc. develops, acquires, produces, and sells equipment for the legal marijuana industry. It develops unique technologies and products to monitor, control, and address the energy and resource intensive nature of indoor cannabis cultivation. The Company’s mission is to acquire intellectual property (IP) and scalable operating companies in the nascent, legal marijuana industry with a focus on disruptive technology, equipment, and related support services. A technology enterprise, Surna has its corporate office in Boulder, Colorado.

Surna’s goal is to dominate the infrastructure, growing, as well as support side of the global cannabis industry. The basis of the Company’s current revenue stream is on its main product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities.

Surna engineers, manufactures, and distributes state-of-the art equipment and systems for Controlled Environment Agriculture (CEA). At present, its specialty is commercial indoor cannabis cultivation. Its business model excludes the production or sale of marijuana. Through its wholly-owned subsidiary, Hydro Innovations, Surna provides a complete line of commercial and small business indoor agriculture equipment.

Surna has its signature water-cooled climate control platform. Its intention is to integrate this and other proprietary technology into a new, commercial-grade power-generating and environmental control system product. The system is undergoing design to provide a near zero waste energy alternative for the cannabis industry.

Surna provides an assortment of services to help from project inception to post production maintenance. These services include consulting, engineering, bio-security, odor control, and installation support. In addition, Surna offers its product family. These products are for climate control, automation, as well as biosecurity.

Moreover, Surna offers its hybrid building solution and also parts and accessories. The design of its hybrid building is for efficiency. This is Surna’s turnkey solution that keeps one’s facility sealed while decreasing energy consumption.

This past November, Surna announced the appointment of Mr. Anthony K. McDonald as its new Chief Executive Officer and President. Mr. McDonald joined the Board as an independent director in September 2018. He holds an engineering degree from West Point and an MBA degree from the Harvard Business School. Mr. McDonald is the author of Cleantech Sell, a guide to new product launches in cleantech, energy efficiency, and resource efficiency.

Surna, Inc. (SRNA), closed Friday's trading session at $0.072605, down 3.90%, on 175,367 volume with 56 trades. The average volume for the last 3 months is 467,216 and the stock's 52-week low/high is $0.050145/$0.485.


Anfield Energy, Inc. (ANLDF)

Streetwise Reports, InvestorsHub, MarketWatch, OTC Markets, Stockhouse, and Investing News reported on Anfield Energy, Inc. (ANLDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Anfield Energy, Inc. engages in the acquisition, exploration, development, and production of mineral properties in the United States. The Company is a uranium development and near-term production enterprise. Anfield is concentrating on two production centers - the Irigary ISR (in-situ recovery) processing plant in Wyoming and the Shootaring Canyon Mill in Arizona/Utah. Anfield Energy is based in Vancouver, British Columbia.

The Company’s commitment is to becoming a top-tier energy-related fuels supplier through creating value via sustainable, efficient growth in its energy metals assets. Its uranium assets comprise conventional mining claims and State leases in southeastern Utah, Colorado, and Arizona. Anfield’s conventional uranium assets include the Velvet-Wood Project, the Frank M Uranium Project, and the Findlay Tank breccia pipe.

The Company’s key asset is the Shootaring Canyon Mill in Garfield County, Utah. The Shootaring Canyon Mill is strategically located within one of the historically most prolific uranium production areas in the United States. Furthermore, it is one of only three licensed uranium mills in the United States. In 2017, Anfield Energy continued advancing the Shootaring Canyon Uranium Mill license towards operational status with the Utah Division of Waste Management and Radiation Control.

Concerning the Irigaray ISR Processing Plant (Resin Processing Agreement), the Company’s ISR mining projects are in the Black Hills, Powder River Basin, Great Divide Basin, and Laramie Basin, Shirley Basin, and Wind River Basin regions in Wyoming. These consist of 2,667 federal mining claims, 56 Wyoming State leases, and 15 private leases acquired from Uranium One in September 2016.

Anfield Energy’s Clarkson Hill project consists of roughly 500 acres of the mineral holdings of the Company. The Clarkson Hill project includes 25 unpatented mining lode claims situated about 20 air miles southwest of Casper, Wyoming.

Anfield will evaluate the feasibility of adding a vanadium processing facility to its Shootaring Canyon uranium mill. This reflects its intention to capitalize on potential opportunities as vanadium continues to become an even-more relevant commodity in the energy sector.

Anfield Energy announced in December of 2017 a conceptual vanadium exploration target at its Velvet-Wood Mine in Utah. BRS Engineering completed an Exploration Target report, entitled "Velvet-Wood Vanadium Exploration Target, National Instrument 43-101, Utah, U.S.A.", with effective date of December 11, 2017 that provides a vanadium exploration target of between 6.3Mlbs and 9.7Mlbs at a grade of between 0.4 percent V2O5 and 0.61 percent V2O5.

Anfield engaged BRS Engineering to update the Company’s NI 43-101 Preliminary Economic Assessment (PEA) related to the Velvet-Wood Mine to include a vanadium milling circuit as part of a production scenario.

Last year, Anfield Energy announced the acquisition of an extensive exploration database of mining projects centered chiefly on uranium and vanadium properties in the Western U.S. The new database, together with the Company’s already considerable uranium database, constitutes one of the largest depositories of uranium exploration data in the Western U.S.

Also last year, Anfield Energy announced that it identified vanadium exploration targets in its recently-acquired exploration database of mining projects in the Western U.S. The targets are in Colorado and Utah. They are considered complementary to the Company’s Utah-based Shootaring Canyon mill as Anfield Energy could include a vanadium processing circuit on this asset. Additionally, these vanadium projects could serve as a potential extended vanadium project pipeline beyond the Velvet-Wood uranium/vanadium project.

Anfield Energy, Inc. (ANLDF), closed Friday's trading session at $0.19, up 3.54%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 33,638 and the stock's 52-week low/high is $0.116/$0.449.


Energy Services of America Corp. (ESOA)

MicroCap Spotlight, OTC Markets, TradingView, Real Pennies, Market Exclusive, Dividend Investor, Capital Cube, Wallet Investor, GuruFocus, MarketWatch, Marketbeat, 4-Traders, Stockhouse, Streetwise Reports, and Barchart reported previously on Energy Services of America Corp. (ESOA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Energy Services of America Corp. provides contracting services for energy related companies. The OTCQB-listed Company primarily serves the gas, petroleum, power, chemical, and automotive industries. However, it does some other incidental work including water and sewer projects. Energy Services of America is the parent company of C.J. Hughes Construction Company and Nitro Electric Company. Energy Services of America is headquartered in Huntington, West Virginia.

The Company’s C.J. Hughes Construction Co, Inc. was established 70 years ago in West Virginia. C. J. Hughes Construction is one of the region’s leading underground pipeline, utility, and facility construction contractors. C.J. Hughes provides a variety of specialized services to the natural gas, petroleum, and water/wastewater industries.

Energy Services of America’s Nitro Construction Services is a “full service” electrical contractor. Nitro provides high voltage, general power/control and instrumentation services. Since 2004, Nitro has grown its Mechanical Services to include pipe fabrication, pipe erection, HVAC/R, and millwright services.

Energy Services of America builds, but does not own, natural gas pipelines for its customers that are part of interstate and intrastate pipeline systems that move natural gas from producing areas to consumption areas. Furthermore, the Company constructs and replaces gas line services to individual customers of the different utility companies. The majority of its customers are in West Virginia, Virginia, Ohio, Pennsylvania, and Kentucky.

Regarding the oil industry, Energy Services of America provides an array of services relating to pipeline, storage facilities, and plant work. For the power, chemical, and automotive industries, the Company provides a complete range of electrical and mechanical installations and repairs. This includes substation and switchyard services, site preparation, equipment setting, pipe fabrication and installation, packaged buildings, transformers, and other ancillary work regarding these.

Pertaining to the gas industry, Energy Services of America mainly engages in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It engages in the construction of interstate and intrastate pipelines, with a concentration on intrastate pipelines.

Energy Services of America’s other services include liquid pipeline construction, pump station construction, production facility construction, and water and sewer pipeline installations. Other services also include different maintenance and repair services and other services related to pipeline construction.

Recently, Energy Services of America announced the filing of its Annual Report on Form 10-K for the year ended September 30, 2018. Net Income available to common shareholders was $2.2 million for the fiscal year ended September 30, 2018. This represents a $2.9 million increase from a Net Loss available to common shareholders of $700,000 in fiscal year 2017.

Revenues were $135.5 million for the fiscal year ended September 30, 2018. This represents a $5.0 million decrease from $140.5 million in fiscal year 2017. The Company had an adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $8.1 million, or $0.57 per share, and an Earnings per Share of $0.16 on a weighted average of 14,234,571 common shares outstanding for fiscal year 2018. The backlog at September 30, 2018 was $71.1 million.

Energy Services of America Corp. (ESOA), closed Friday's trading session at $1.05, down 2.78%, on 8,527 volume with 10 trades. The average volume for the last 3 months is 6,529 and the stock's 52-week low/high is $0.536/$1.389.


Biostage, Inc. (BSTG)

Investors Hub, Stock News Gazette, StockNewsJournal, Simply Wall St,, Barchart, The Street, StockTwits, Zacks,, and reported on Biostage, Inc. (BSTG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Biostage, Inc. is a biotechnology company based in Holliston, Massachusetts. It is developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea. The Company formerly went by the name Harvard Apparatus Regenerative Technology, Inc. It changed its corporate name to Biostage, Inc. in March 2016. Established in 2007, Biostage lists on the OTC Markets Group’s OTCQB.

Biostage is developing bioengineered organ implants based on its Cellframe™ technology. This technology combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants.

Cellspan implants are undergoing development to treat life-threatening conditions of the esophagus, bronchus or trachea with the hope of considerably improving the treatment paradigm for patients. Biostage, based on its preclinical data, has selected life-threatening conditions of the esophagus as the initial clinical application of its technology.

Biostage’s novel Cellframe™ technology is engineered to stimulate the body’s signaling pathways and natural healing process to regenerate and restore organ function. The Company’s Cellframe technology is based on more than 20 years of scientific progress in the fields of tissue engineering, cell biology, and material science. Cellframe technology combines the best attributes of a synthetic scaffold with tissue engineering and cell biology.

The Cellspan implant is delivered directly to the site where tissue regeneration is required. It is intended to play a pivotal role in the success of in situ tissue regeneration through providing stem cell-derived biological signals, and three-dimensional guidance and support, for cell growth and regeneration.

Moreover, Biostage’s plan is to establish a presence in China to address the largest incidence of esophageal cancer worldwide. The Company has built a dedicated internal team of materials scientists, engineers and biologists. They are working with Biostage’s external collaborators to bring Biostage products to the patients who need them as fast as possible.

This past March, Biostage announced it was awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the Eunice Kennedy National Institute of Child Health and Human Development (NICHD). The NICHD is part of the National Institute of Health. NICHD awarded Biostage the grant as part of its mission to "ensure that every person is born healthy and wanted, and that all children have the chance to achieve their full potential for healthy and productive lives."

The grant funding will support Biostage's development and preclinical testing of its Cellspan™ Esophageal Implant (CEI) for treatment of pediatric esophageal atresia. The Company’s Sumati Sundaram, PhD and Christine Finck, MD, FACS, Surgeon-In-Chief at Connecticut Children's Medical Center are the main investigators on this grant.

Recent highlights for Biostage include announcing the first successful in-human use of a Cellspan™ implant to regenerate a patient's esophagus. Furthermore, the Company published successful results of a pre-clinical study demonstrating esophageal regeneration in large animals.

Biostage, Inc. (BSTG), closed Friday's trading session at $2.24, up 7.69%, on 1,347 volume with 9 trades. The average volume for the last 3 months is 2,459 and the stock's 52-week low/high is $1.91/$5.85.


iCo Therapeutics, Inc. (ICOTF)

Amigo Bulls, Wallet Investor, Zacks, Money Hub, Street Insider, InvestorsHub, Stockhouse, Capital Cube, TheMicrocapNews, The Hot Penny Stocks, Penny Stock Tweets, OTC Markets Group, Stockwatch, TradingView, Wall St Report, Vantage Wire, MarketWatch, GuruFocus, and Clever Markets reported earlier on iCo Therapeutics, Inc. (ICOTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

iCo Therapeutics, Inc. identifies existing development stage assets for use in underserved ocular and infectious diseases. It owns the worldwide exclusive rights to an oral delivery system - Amphotericin B (Amp B) -for life-threatening infections. Amphotericin B is the gold standard for systemic antifungal drugs. It is one example of a well-established, highly efficacious systemic antifungal drug that has a 50-year history of intravenous therapy. OTCQB-listed, iCo Therapeutics is based in Vancouver, British Columbia.

The Company centers its efforts on development instead of research. iCo’s business model aims to acquire the rights to drugs that are either off-patent, currently approved or near commercialization, and develop them through redosing or reformulating them for new or expanded labels. iCo has its partnership with Immune Pharmaceuticals (IMNP), which is in a number of Phase 2 studies involving iCo-008.  iCo-008 is also known as Bertilimumab or CAT-213.

iCo-008 is a human monoclonal antibody targeting eotaxin-1, a member of the chemokine family of proteins, which acts as a messenger between the cells of the immune system. Immune Pharmaceuticals initiated a Phase 2, double-blind, placebo-controlled study with iCo-008 in 90 patients with moderate-to-severe ulcerative colitis.

iCo Therapeutics continued to advance its Oral Amphotericin B Delivery System (Oral Amp B) in 2016. Amphotericin B is a well-known approved drug for the treatment of fungal and parasitic infections. The Company is developing a proprietary oral reformulation of Amphotericin B.

This past November, iCo Therapeutics announced that it now has sufficient drug supply for a proposed mid-staged clinical trial that may be as large as 90 patients in size, investigating the efficacy and safety study of its oral Amphotericin B (oral Amp B) candidate. Moreover, based on discussions with anti-fungal experts, the Company’s intention is to conduct a comparison of oral Amp B to an approved azole drug in this proposed oral Amp B efficacy study in the area of women's health where recurrent candidiasis is common.

iCo’s licensee earlier announced a $5M USD financing for continued development of iCo-008. In addition, new clinical data has been reported in support of the drug candidate in bullous pemphigoid and pre-clinical data announced which is supportive of the potential use of iCo-008 in asthma.

iCo Therapeutics, Inc. (ICOTF), closed Friday's trading session at $0.0507, even for the day, on 14,000 volume. The average volume for the last 3 months is 4,664 and the stock's 52-week low/high is $0.0209/$0.2035.


Millennial Lithium Corp. (MLNLF)

Streetwise Reports, Small Cap Leader, Stockpulse, The Street, Penny Stock Tweets, Investing News, TradingView, OTC Markets, TipRanks, Insider Financial, Stockwatch, Junior Mining Network, Morningstar, Barchart, Stockhouse, 4-Traders, Metals News, Investors Hub, and Zacks reported on Millennial Lithium Corp. (MLNLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Millennial Lithium Corp. is an emerging exploration and development company headquartered in Vancouver, British Columbia. The Company is focusing on world class lithium assets in Argentina. Its commitment is to advancing the Pastos Grande Lithium project and the Cauchari East lithium project. Millennial Lithium’s shares trade on the OTC Markets Group’s OTCQX.

Millennial Lithium controls greater than 35,000 hectares of claims in the core of the Lithium Triangle. The Lithium Triangle is home to the world’s most prolific lithium deposits.

The Cauchari East Project is one of the world’s most prospective, shovel-ready lithium brine development projects. It is at the heart of the Lithium Triangle.

The ready availability of plenty of regional mining infrastructure offers the prospect of lowered Capex (capital expenditures) and operational expenditures at Cauchari East. Millennial Lithium is working towards the completion of a 43-101 resource calculation.

The Pastos Grandes Project is the Company’s flagship project. This Project is in Salta Province, Argentina. Currently, the Pastos Grandes Project covers 6,361 hectares. This makes Millennial Lithium the most active company in this expansive salar.

Millennial Lithium has an option to acquire 100 percent of the Pastos Grandes Lithium Project. The timeline to production is three years and 9 wells have been drilled and $9 Million spent in development.

On December 21, 2017, Millennial Lithium entered into the final agreement with the Salta Provincial Energy and Mining Company (REMSA) for the acquisition of 2,492 hectares of claims strategically located in the Pastos Grandes Salar and neighboring the Company’s current land holdings there. Completion of this acquisition brings Millennial Lithium’s holdings at Pastos Grandes to 8,664 hectares.

In February 2018, Millennial Lithium announced that it filed a Preliminary Economic Assessment (PEA Report) concerning its Pastos Grandes Project in the province of Salta, Argentina. The PEA Report, titled "Preliminary Economic Assessment of the Pastos Grandes Project Salta Province, Argentina" and dated February 23, 2018, was prepared by WorleyParsons.

Recently, Millennial Lithium reported that it received the environmental permit to begin exploration on the properties awarded to it by the Salta Provincial Energy and Mining Company (REMSA). The REMSA Properties form a part of Millennial Lithium’s Pastos Grandes project.

Millennial Lithium’s intention is to complete a Feasibility Study (FS) of the Pastos Grandes project, with the additional studies to support it. This includes a production well field model and reserves estimation.

This month, Millennial Lithium reported that it was granted the environmental permit to conduct geophysics and a drilling program of up to 6 wells on its Cauchari East lithium brine target in Jujuy Province, Argentina.

Farhad Abasov, Millennial Lithium’s President and Chief Executive Officer, stated, "We are pleased to have reached this milestone towards advancing exploration in this increasingly important lithium producing region. We are committed to exploring this target which adjoins known mineralization as defined by the two other explorers and developers in the Cauchari-Olaroz basin and which hosts the only new brine producer of the past 30 years, Orocobre's Salar de Olaroz Lithium Facility.”

Millennial Lithium Corp. (MLNLF), closed Friday's trading session at $1.068, up 2.87%, on 6,387 volume with 10 trades. The average volume for the last 3 months is 11,166 and the stock's 52-week low/high is $0.67/$3.87.


MPX Bioceutical Corporation (MPXEF)

Penny Stock Hub, Stockhouse, MarketWatch, InvestorsHub, Stockwatch,, 4-Traders, TradingView, OTC Markets, OTC Dynamics, Jet Life Penny Stocks, TalkMarkets, Barchart, Investing News Alerts, and High Rising Stocks reported on MPX Bioceutical Corporation (MPXEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

MPX Bioceutical Corporation, by way of its wholly-owned subsidiaries in the U.S., provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona. These businesses operate under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. In addition, MPX Bioceutical has operations in Massachusetts.

MPX Bioceutical is based in Toronto, Ontario. The Company formerly went by the name The Canadian Bioceutical Corporation. It changed its corporate name to MPX Bioceutical Corporation in November of 2017. The Company lists on the OTCQB.

MPX Bioceutical is a multi-state diversified cannabis company. It has operations centered in the U.S. in the adult use and medical cannabis markets. It has completed its agreement to acquire GreenMart operations in Nevada. Also, it signed non-binding Letters of Intent (LOI’s) to purchase dispensary and production licenses in Maryland. Moreover, MPX has applied for a license in Canada.

Concerning Pharma-grade products, the Company signed a definitive agreement to establish a joint venture (JV) with Panaxia. This JV is to develop proprietary, smokeless pharma-grade products using cannabis.

In April, MPX Bioceutical announced the official opening of its newest “Health for Life” medical marijuana dispensary in the Metropolitan Phoenix area. This brings the number of dispensaries under MPX management in Arizona’s Sun Valley to four. The Crimson dispensary will offer the full range of MPX concentrates, a broad assortment of cannabis flower, and a wide selection of 3rd party, processed cannabis-infused edibles.

Additionally, in April, MPX Bioceutical announced that it signed a Letter of Intent (LOI) to acquire 100 percent of the issued and outstanding shares of Canveda, Inc.  Canveda is a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).

Canveda is a private company operating in Peterborough, Ontario. It operates from a completely built-out facility, which is ready to start its initial production run and is capable of producing about 1,000-1,200 kilograms of high quality cannabis flower each year. MPX Bioceutical will acquire the Canveda Shares for CDN$18 million.

MPX Bioceutical Corporation (MPXEF), closed Friday's trading session at $0.74575, up 1.84%, on 617,277 volume with 352 trades. The average volume for the last 3 months is 1,285,587 and the stock's 52-week low/high is $0.468/$0.97.


NowNews Digital Media Technology Co. Ltd. (NDMT)

CapitalCube and OTC Markets reported on NowNews Digital Media Technology Co. Ltd. (NDMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NowNews Digital Media Technology Co. Ltd. (NowNews) is a media enterprise. The OTCQB-listed Company provides news and multimedia platform services. In essence, NowNews is a media holding company concentrating on the worldwide Chinese market. The Company’s holdings in the media space include digital media, movie production and distribution, and music copyright. NowNews is headquartered in Taipei City, Taiwan.

The Company’s digital media business engages in creating, collecting, and distributing news and information through its website and applications on mobile phones or tablets. Its subsidiary is NOWnews Network Co. Ltd. (NOWnews). This is the largest online self-produced news content provider of Taiwan. Furthermore, it is the only Taiwanese online news website fully accessible in Mainland China.

NowNews’ movie production and distribution business engages in Internet movie, Internet drama, and Internet show production. It also engages in foreign movie import and production, movie marketing and advertising, and the Internet personality business.

NowNews’ music copyright business owns copyrights to over 3,000 hit pop songs. This business provides a complete range of Karaoke products. Additionally, NowNews has investments in the banking industry in Southeast Asia.

Recently, NowNews Digital Media announced that its majority-owned subsidiary, NOWnews Network Co. Ltd. (NOWnews), agreed to cooperate with Grace Intelligent Blockchain Technology Co. Ltd. to build a blockchain based media platform. NOWnews will build a new decentralized blockchain based media platform.

On the platform, the online network users will be divided into four roles. These are author, reviewer, reader, and storage provider. On this decentralized platform, people worldwide can become authors and publish local news.

China Information Technology, Inc. (CNIT) announced recently that it entered into an exclusive distribution agreement with NowNews Digital Media Technology. CNIT is a foremost provider of internet-based ad distribution and ad display terminal sharing systems in China. With this agreement, NowNews will act as the exclusive partner of CNIT in Taiwan to promote CNIT’s new-media sharing business.

NowNews Digital Media Technology Co. Ltd. (NDMT), closed Friday's trading session at $2.00, up 100.00%, on 200 volume with 2 trades. The average volume for the last 3 months is 218 and the stock's 52-week low/high is $1.00/$3.50.


Pilbara Minerals Limited (PILBF)

Penny Stock Tweets, TipRanks, StreetSignals, OTC Markets, WalletInvestor, Barchart, MarketWatch, Stockhouse, InvestorsHub, 4-Traders, GuruFocus, YCharts, Hot Copper, Wallmine, Stockscores, Investors Hangout, and The Subway Trader reported on Pilbara Minerals Limited (PILBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Pilbara Minerals Limited engages in the exploration, evaluation, and development of mineral resources in Australia. The Company is an emerging lithium and tantalum producer. Its emphasis is on the development of its world-class 100 percent owned Pilgangoora Lithium-Tantalum Project, positioned roughly 120 kms from Port Hedland in the Pilbara area of Western Australia. Listed on the OTC Markets, Pilbara Minerals has its corporate office in West Perth, Australia.

The Company’s goal is to fast-track Pilgangoora towards production to capitalize on the widely anticipated shortfall of lithium in worldwide markets over the next ten years. The Pilgangoora Lithium-Tantalum Project has been confirmed as one of the largest spodumene (lithium pyroxene) and tantalite projects globally. It is set to be developed into one of the world’s largest lithium mines, also producing tantalite as a valuable by-product.

Pilbara Minerals’ other project is Mt Francisco. It hosts the last remaining large occurrence of outcropping pegmatites in close proximity to Port Hedland. Mt Francisco is considered to represent one of the highest quality lithium exploration/development assets in the Pilbara region outside of the Company’s world-class Pilgangoora Project.

Regarding Mt Francisco, Pilbara Minerals acquired a 51 percent interest in March of 2017. It has the right to earn up to 80 percent in stages by funding $1M worth of exploration and completing a definitive feasibility study (FS) until decision to mine.

Concerning the Pilgangoora Project, significant increases in the Global Resource at Pilgangoora have reinforced its status as Australia's premier lithium development Project. The latest Global Resource (as published in January 2017) incorporates all the results of a successful drilling program completed from February 2016 to December 2016. It consists of a Global Measured, Indicated and Inferred Resource of 156.3 million tonnes grading 1.25 percent Li2O (lithia) and 138ppm Ta2O5 (tantalite) containing 1.57 million tonnes of lithium oxide and 39 million pounds of Ta2O5.

The 2Mpta Pilgangoora Project is fully funded. It is advancing rapidly to production, targeting first concentrate from June 2018. Cornerstone offtake partners are General Lithium, Ganfeng Lithium and Great Wall Motors.

Pilbara Minerals Limited (PILBF), closed Friday's trading session at $0.51705, up 5.81%, on 3,200 volume with 3 trades. The average volume for the last 3 months is 10,164 and the stock's 52-week low/high is $0.352/$0.844.


Costar Technologies, Inc. (CSTI)

Zacks, OTC Dynamics, Stockflare, Street Insider, Stockwatch, VentureLine, Penny Stock Tweets, Barchart, Amigo Bulls, Stockhouse, Simply Wall St, OTC Markets, InvestorsHub, 4-Traders, Morningstar, Marketbeat, MarketWatch, YCharts, and Infront Analytics reported on Costar Technologies, Inc. (CSTI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Costar Technologies, Inc. develops, designs, manufactures and distributes a range of security solution products. In addition, it develops, designs and distributes industrial vision products to observe repetitive production and assembly lines, thus increasing efficiency by detecting faults in the production process. Costar Technologies has its corporate office in Coppell, Texas.

Costar Technologies consists of four companies. These are CohuHD Costar, Costar Video Systems, Innotech, and IVS Imaging. The Company’s security solution products include surveillance cameras, lenses, digital video recorders, as well as high-speed domes. The combined product portfolio comprises surveillance cameras, recorders, monitors, lenses, cables, and other electronic accessories.

Costar Technologies provides solutions for financial institutions, educational facilities, retail stores, and manufacturing plants. It also provides solutions for highways, government buildings, military bases, borders, and other applications.

Costar Video Systems is a top provider of electronic security products for the video surveillance market. IVS Imaging is the industrial video division of Costar Video Systems. IVS Imaging distributes video surveillance, industrial video, machine vision and other OEM (original equipment manufacturer) products from the world’s foremost manufacturers.

CohuHD Costar has for more than six decades manufactured electronic security products for the video surveillance market. Costar Technologies has manufacturing capabilities in the United States, China, and Korea.

The Company’s business strategy is to focus on Retail, Financial, Transportation, and Defense markets. Its research and development (R&D) efforts are dedicated to on-board camera analytics. Moreover, its strategy is to add $5-$10 Million of revenue per annum via acquisitions.

Costar Technologies’ business strategy also includes infrastructure improvements. This includes Net Suite Implementation; Supply Chain Improvements; Solution Selling and reducing customer concentration.

Recently, Costar Technologies announced its financial results for Q1 ended March 31, 2018. The Company realized Revenue of $10,917. This represents an increase of $1,346 or 14.1 percent from the quarter ended March 31, 2017.

It realized GAAP Net Income of $50 or $0.03 per share based on 1,589 fully diluted shares outstanding, versus a GAAP Net Loss of ($159) or ($0.11) per share based on 1,493 fully diluted shares for the quarter ended March 31, 2017.

Costar Technologies, Inc. (CSTI), closed Friday's trading session at $10.00, up 3.63%, on 3,394 volume with 10 trades. The average volume for the last 3 months is 208 and the stock's 52-week low/high is $6.01/$11.89.


The QualityStocks Company Corner

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

Transcanna Holdings Inc. (CSE: TCAN) ("TransCanna" or the "Company") is pleased to announce that TCM Distribution, Inc. ("TCMD"), the non-profit entity managed by the Company has received from the state of California its temporary distributor license. On December 31st TCMD submitted its permanent distribution license application to the state of California.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $1.37, up 28.04%, on 224,300 volume with 127 trades. The stock's 52-week low/high is $0.769/$1.07.

Recent News


Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) is following its strategic growth plan by applying for a OTCQB Venture Market listing, which it believes will make it easier to attract more institutional and retail investors and offer ease of trading in the company’s common shares (

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.61, up 1.67%, on 15,000 volume with 87 trades. The average volume for the last 3 months is 21,004 and the stock's 52-week low/high is $0.46/$1.55.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX).

Chinese-language investment news outlet Inc. (OTCQB: CIIX) is launching its first self-branded rice wine alcohol product, Hemp Wine, under the auspices of its wholly owned cannabis industry subsidiary, CBD Biotechnology Co. Ltd., less than a month before the advent of Chinese New Year, which will mark the commencement of the “Year of the Pig.” In Chinese culture, pigs ( are the symbol of wealth, and the elemental cycle of Earth that will occur with the new year portends a season of “social butterflies with friends from all walks of life” who “have fortunate lives and can find happiness” – certainly a cause for celebration. Also today, the company was featured on MoneyTV with Donald Baillargeon, which covered how CEO Warren Wang recently announced the launch of hemp wine and discussed recent progress.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.49, up 4.26%, on 85,997 volume with 68 trades. The average volume for the last 3 months is 168,408 and the stock's 52-week low/high is $0.365/$1.25.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint Inc. (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is internationally-syndicated and reviews money-focused topics, featuring in-depth CEO and executive interviews from various companies offering insights into their operations and future outlooks. To view the full press release, visit: CannabisNewsAudio announces the Audio Press Release (APR) titled “New Laws Set Up US Cannabis Industry for Explosive Growth,” featuring SinglePoint, Inc. (OTCQB: SING). To hear the CannabisNewsAudio version, visit: To read the full editorial, visit:

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.01999, up 0.45%, on 4,038,691 volume with 224 trades. The average volume for the last 3 months is 6,269,134 and the stock's 52-week low/high is $0.0106/$0.082.

Recent News


Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) advanced throughout 2018 by employing a business strategy to create the foundations of a loan portfolio that produces revenue with monthly interest income and that also produces value for shareholders. To view the full article, visit:

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.2073, even for the day, on 1,200 volume. The average volume for the last 3 months is 287 and the stock's 52-week low/high is $0.10/$0.505.

Recent News


Plus Products Inc. (CSE: PLUS) (OTC: PLSPF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLSPF).

Plus Products Inc. (CSE: PLUS), the leading cannabis edibles brand in California, increased its edibles market position from number four in Q2 of 2018 to number one in Q3, according to data released from BDS Analytics. This marks ( the company as the number one best-selling cannabis-infused edibles brand in California, “the largest and most competitive cannabis market in the world.”

Plus Products Inc. (CSE: PLUS) (OTC: PLSPF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLUS), closed the day's trading session at $3.45, off by 8.00%, on 55,999 volume with 106 trades. The average volume for the last 3 months is 98,824 and the stock's 52-week low/high is $2.81/$4.25.

Recent News


The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a vertically integrated Canadian company producing premium cannabis products, holds a strategic advantage over larger companies as the impending supply glut approaches, thanks in part to its low operating costs and irradiation-free products. To view the full article, visit:

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $4.03, off by 4.05%, on 87,382 volume with 136 trades. The average volume for the last 3 months is 81,259 and the stock's 52-week low/high is $2.74/$8.00.

Recent News


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America, Inc. (OTCQB: MCOA) was featured today in a report by CannabisNewsWire. It seems South Carolina is next in line to act upon the growing popularity of marijuana across the U.S. Two legislators have tabled a bill that, if passed, would allow patients to start using medical marijuana.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.015225, off by 1.84%, on 8,329,681 volume with 264 trades. The average volume for the last 3 months is 14,020,498 and the stock's 52-week low/high is $0.0115/$0.049.

Recent News


Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC: REFG) was featured today in a report by CannabisNewsWire. It seems South Carolina is next in line to act upon the growing popularity of marijuana across the U.S. Two legislators have tabled a bill that, if passed, would allow patients to start using medical marijuana.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.022, up 4.76%, on 700,698 volume with 46 trades. The average volume for the last 3 months is 431,720 and the stock's 52-week low/high is $0.0127/$0.075.

Recent News


Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $2.20, up 8.37%, on 2,380 volume with 7 trades. The average volume for the last 3 months is 4,664 and the stock's 52-week low/high is $1.52/$5.00.

Recent News



The QualityStocks Daily Newsletter would like to spotlight GTX Corp (GTXO).

GTX Corp (GTXO), a For Profit For Purpose company, designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business. Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (, there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • P.E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp (GTXO), closed the day's trading session at $0.0099, up 3.12%, on 222,499 volume with 16 trades. The average volume for the last 3 months is 199,959 and the stock's 52-week low/high is $0.006/$0.412.

Recent News


Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software, Inc. (PFSF) is an emerging technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is building “BoaPin,” a subscription-based e-commerce trading platform focused on cross border trade expansion with an international emphasis. The multi-faceted e-commerce platform is scheduled for launch in Q1 of 2019.

The Company is uniquely positioned to deliver a B2B and B2C intelligent e-commerce trade platform which will provide various solutions, data, applications and tools for subscribers, including IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure, multi-lingual communication, fintech, digital marketing, smart contracts, commodities search/match applications, customs clearance, taxation data, product advertising and logistics solutions.

Through smart contract technology for global supply chain management, BoaPin is designed to improve product traceability and deliver solutions to its subscribers for product certification, marketing, logistics, commodities search/match interface, trade finance, cross border payment solutions and customs clearance. Some of the tools available to execute these capabilities include cross border payments, blockchain solutions, smart contracts and multilingual access.

With these features at hand, the company is targeting several key industries where its online applications and solutions could have significant corporate impact in various forms, including: agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management.

Business Model

Pacific Software initially will focus on Brazil and China for BoaPin. After paying a registration fee to utilize the online trade portal, subscribers to the platform will have access to a variety of tools and features that may enhance and increase revenue initiatives by showcasing their commodities and products for sale or trade.

Buyers of the commodities, products or services will pay a transaction fee only to the company which could materialize in the form of cash, cash equivalents, royalties or in-kind fees.

As the company executes its strategy, the online trade business is anticipated to generate significant revenue from subscribers obtained from regionally and federally organized Brazilian Trade Associations. The members wish to market their commodities or products, and the portal users or buyers materialize from China, Hong Kong and surrounding countries. As a result, this business model may be organized separately in the company’s wholly owned subsidiary, incorporated as HyperSoft Ventures, which could generate appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The stock's 52-week low/high is $3.50/$5.50.

Recent News


Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.


Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $0.79, even for the day, on 17,131 volume with 26 trades. The average volume for the last 3 months is 32,279 and the stock's 52-week low/high is $0.59/$2.09.

Recent News


Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $1.8369, off by 0.16%, on 6,081 volume with 22 trades. The average volume for the last 3 months is 21,190 and the stock's 52-week low/high is $1.47/$5.46.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.